Skip to main content

The big wide world of research


Some of the HPSers have been having a conversation lately about the state of research. We are an impatient group. You can’t blame us. We’re watching our friends grow sicker, need lung transplants etc. We have an ever growing younger generation as people get diagnosed earlier and earlier, and we want them to have a future better than ours. 

Yet research seems to move so slow. We are all a bit sad that currently there is no clinical trial on the horizon. 

Sometimes it’s a matter of perception. When the drug trial was underway HPSers were in and out of the NIH all the time. They would share about their trips and there was a tangible feeling that things were happening. 

Now, things are happening, but we don’t hear about them as often. We hear about them at conference for a day. I know (because I’m on the board) that there’s more afoot than even was shared at conference, but was so preliminary, it wasn’t appropriate to share in a public setting with patients. The thing is we don’t see that. 

It’s amazing how quickly the excitement of one day of research updates can be overwhelmed by the day to day realities of living with HPS. 

I wish I could be a fly on the all in labs working on HPS. I wish I could visit to take a picture of our researchers hard at work. I know they are, but I want to show everyone. I want them to see it in a more real way. 

In the meantime, this article was shared with me today. It’s a reminder that not just HPS research moves forward. Research in general moves forward and somewhere out there, will likely yield a discovery that will, one day, help us as well. 

Here’s the article. PLEASE keep in mind it’s early going with this idea, and it seems from the article, it’s only intended for emergencies. But imagine, if there was a drug that could put oxygen in our blood without needing our lungs to work at all. Wow! 

http://www.techwench.com/scientists-invent-oxygen-particle-that-if-injected-allows-you-to-live-without-breathing/

Comments

Popular posts from this blog

Ratner's Cheesecake

Here's another recipe from Toby! Thanks Toby......and I'll get the others posted soon! Ratner's Cheesecake and plain cookies Ratner's was a Jewish dairy restaurant in the lower East Side of Manhattan. This recipe, from my disintegrating, no longer in print Ratner's cookbook, is the closest I've ever gotten to reproducing the rich, heavy cheesecake my mother made when I was a kid. It's worth the time it takes to prepare and every last calorie. Dough Can be prepared in advance. Makes enough for two cakes. Can be frozen or used to make cookies – see recipe below. 1 cup sugar 1 teaspoon vanilla extract 1 cup shortening 1 teaspoon lemon extract 1 cup butter 2 eggs 3 cups sifted cake flour ½ teaspoon salt 2 cups all purpose flour 1 teaspoon baking powder 1. In a bowl, combine all ingredients with hands. Refrigerate 3 -4 hours, or preferably overnight. Filling (for

The next generation with Hermansky-Pudlak Syndrome

I'm so behind on posting about the trip to Puerto Rico. Since the episode of Mystery Diagnosis on Hermansky-Pudlak Syndrome ran right after we got home, it's been a little busy. These, however, are my favorite pictures from Puerto Rico. I know, not pretty senery etc - but these little guys and gals inspire me. They are the next generation of folks with HPS, and if we keep up the hard work, they will live better lives because of it. They motivate me.

Some good news about Pirfenidone

Below is a press release from Intermune, the company that makes Pirfenidone. They have essentially reviewed the various clinical trials going on, and decided that Pirfenidone is safe and well tolerated. That would pretty much go along with what we've observed in the HPS community as well. We have a few folks that have been on the drug since the late 90s and continue to do well. Of course, as a journalist, I do have to say consider the source - but at the same time, as someone in a Pirfenidone trial, it's good to know. Results of Comprehensive Safety Analysis of pirfenidone In IPF Patients Presented At European Respiratory Meeting - Analysis shows safety and tolerability of pirfenidone across four clinical trials - VIENNA, Sept. 14 /PRNewswire-FirstCall/ -- InterMune, Inc. (Nasdaq: ITMN ) today announced that the results of a comprehensive review of safety data from four clinical studies were presented at the 2009 European Respiratory Society Annual Congress in Vienna, Austria